Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

UMMAH RELIEF INTERNATIONAL

NPI: 1346915923 · ELGIN, IL 60123 · Clinical Medical Laboratory · NPI assigned 08/16/2021

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official KHAN, MUHAMMAD controls 14+ related entities in our dataset. Read more

$328K
Total Medicaid Paid
8,558
Total Claims
5,949
Beneficiaries
5
Codes Billed
2022-04
First Month
2022-12
Last Month

Provider Details

Authorized OfficialKHAN, MUHAMMAD (PRESIDENT)
NPI Enumeration Date08/16/2021

Related Entities

Other providers sharing the same authorized official: KHAN, MUHAMMAD

ProviderCityStateTotal Paid
AMERICAN INSTITUTE OF MEDICAL SOLUTIONS, LLC DAYTON OH $22.54M
ESPOIR LAB INC CHICAGO IL $4.34M
MUHAMMAD J.S.KHAN MD,PC ELMHURST NY $971K
SAGINAW VALLEY MEDICAL CARE PLC SAGINAW MI $842K
AMERIBEST HOME CARE CINCINNATI OH $478K
TRICITY INTERNISTS SAGINAW MI $358K
M N KHAN PC BLOOMFIELD HILLS MI $228K
SOUTHWEST KANSAS CARDIOLOGY, LLC DODGE CITY KS $210K
EPIC HEART & VASCULAR CENTER PLLC HOUSTON TX $91K
KHAN MEDICAL CLINIC, PLLC COTULLA TX $58K
DALLAS MD ASSOCIATES LLC FRISCO TX $43K
CENTRAL FLORIDA INTERNISTS, INC. SAINT CLOUD FL $40K
MIDMICHIGAN GERIATRICS PLC SAGINAW MI $26K
COMPREHENSIVE POSTACUTE CARE PLLC TACOMA WA $5K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 8,558 $328K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 2,311 1,518 $160K
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1,850 1,399 $70K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,302 1,513 $50K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 2,064 1,491 $47K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 31 28 $1K